| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | CN101006091A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 07/25/2007 | CN101006079A 嘧啶衍生物 Pyrimidine derivatives |
| 07/24/2007 | USRE39743 Antibiotics, bactericides |
| 07/24/2007 | US7247650 Macrolides and methods for producing same |
| 07/24/2007 | US7247641 Compounds, derivatives, compositions, preparation and uses |
| 07/24/2007 | US7247634 Rifamycin derivatives effective against drug-resistant microbes |
| 07/24/2007 | US7247262 Polymer matrix and a compound of a photochromic moiety and an oligomer of polyether, polyalkylene polyfluoroalkylene, polyfluoroalkylenyloxy, polydi(C1 to C10 hydrocarbyl)siloxane, polysilicene acid; the photochromic adduct does not become covalently tethered to the polymer matrix |
| 07/19/2007 | WO2007079957A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/19/2007 | WO2007041052B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/19/2007 | WO2007017828A3 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 07/19/2007 | US20070167445 Androgen receptor modulator compounds and methods |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167430 Compounds useful in therapy |
| 07/19/2007 | US20070167428 Thienopyrroles as antagonists of gnrh |
| 07/19/2007 | CA2633722A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/18/2007 | EP1644392B1 Rapamycin carbohydrate derivatives |
| 07/18/2007 | EP1636239B1 Indole derivatives with an improved antipsychotic activity |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | CN1326523C Atineoplastic combinations |
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/18/2007 | CN101001840A Therapeutic compounds: pyridine as scaffold |
| 07/17/2007 | US7244843 Modulators of serotonin receptors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244727 Fused bicyclic nitrogen-containing heterocycles |
| 07/12/2007 | WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | WO2007077893A1 Therapeutic agent for liver disease and hepatic function-ameliorating agent |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007077122A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/12/2007 | WO2007039816A3 Fermentation processes for the preparation of tacrolimus |
| 07/12/2007 | WO2007038209A3 Fused tetracyclic mglur1 antagonists as therapeutic agents |
| 07/12/2007 | WO2006078809A3 Method for the preparation of maytansinoid esters |
| 07/12/2007 | WO2006050170A3 Medical devices containing rapamycin analogs |
| 07/12/2007 | WO2006009718A3 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 07/12/2007 | US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/12/2007 | US20070161672 Compounds |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161661 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanesulfonate |
| 07/12/2007 | US20070161660 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea maleate |
| 07/12/2007 | US20070161659 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate |
| 07/12/2007 | US20070161658 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl) phenyl)urea camphorsulfonate |
| 07/12/2007 | US20070161657 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrobromide |
| 07/12/2007 | US20070161656 N-(4-(4-aminothieno[2,3-d]pyrimidin-5-YL)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea crystalline form 2 |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161630 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/12/2007 | US20070161627 Antibacterial agents |
| 07/12/2007 | US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161618 Isothiourea derivatives |
| 07/12/2007 | US20070160646 Stent coated by a compound |
| 07/12/2007 | CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | CA2634120A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1805278A1 Photochromic h-annellated benzo(f)chrome-derivatives |
| 07/11/2007 | EP1805185A1 Hydroxy amide acetals and their use in coatings |
| 07/11/2007 | EP1805144A1 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | CN1997651A Oxidative degradation products of atorvastatin calcium |
| 07/11/2007 | CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/11/2007 | CN1994301A Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 07/11/2007 | CN1324964C Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241771 Prepared by dissolving 42-O-(2-hydroxy)ethyl-rapamycin in a solution containing an organic solvent and an aqueous buffer having a pH of 4 to 10; and extracting the SDZ-RAD Isomer C into an organic solvent; immunosuppressive, anti-inflammatory, antifungal, antiproliferative and antitumor agents |
| 07/10/2007 | US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 07/10/2007 | CA2549561C 36- derivatives of rifamycins |
| 07/05/2007 | WO2007075884A2 Androgen receptor modulator compounds and methods |
| 07/05/2007 | WO2007075872A2 Nitroimidazole compounds |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007074995A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | WO2006069080A3 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | US20070155777 Antiinflammation agents |
| 07/05/2007 | US20070155776 Thienopyridine and furopyridine kinase inhibitors |
| 07/05/2007 | US20070155758 tyrosine kinase inhibitor; cancer, retinopathy, psoriasis |
| 07/05/2007 | US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 07/05/2007 | US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 07/05/2007 | US20070154890 Method for detecting biomolecule, labeling dye used therefore, and labeling kit |
| 07/05/2007 | DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2635255A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | CA2634907A1 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 07/05/2007 | CA2631686A1 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 07/05/2007 | CA2631661A1 Nitroimidazole compounds |
| 07/04/2007 | EP1802635A2 Heteroatoms-containing tricyclic compounds |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | CN1993368A Cci-779 derivatives and methods of making same |
| 07/04/2007 | CN1993367A Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 07/04/2007 | CN1993360A Condensed pyridines as kinase inhibitors |
| 07/04/2007 | CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 07/04/2007 | CN1324013C Aryl Fused azapolycyclic compounds |
| 07/03/2007 | US7238694 Rifamycin imino derivatives effective against drug-resistant microbes |
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | US7238689 Crop and weed selectivity |
| 07/03/2007 | CA2168021C Vasoconstrictive dihydrobenzopyran derivatives |
| 06/28/2007 | WO2007073095A1 Process for the preparation of (s)-(+)-clopidogrel on a solid-phase |
| 06/28/2007 | WO2007072151A1 8-pyrazinyl-s-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents |
| 06/28/2007 | WO2007071966A1 Pyrimido- [4, 5-b] -oxazines for use as dgat inhibitors |
| 06/28/2007 | WO2007071434A1 Antiviral 2-carboxy-thiophene compounds |
| 06/28/2007 | WO2007070984A1 Spiroketals |